RoActemra 20 mg/mL concentrate for solution for infusion, RoActemra 20 mg/mL concentrate for solution for infusion clinical trials

Non-inferiority study of TOCILIZUMAB in dose-banding versus dose-weight in rheumatoid arthritis with low activity or clinical remission

This study looks at a different way to give RoActemra (tocilizumab) for rheumatoid arthritis. We want to see if giving a standard dose based on how well you're doing, rather than your weight, works just as well for patients with low disease activity or who are in remission.